LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) sold 14.5% of their position (5.69K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2025ACC: 0001415889-25-006316
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
-5.69K
Net shares
Net seller
$13.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.25K acquired · 21.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.25K
Price / share
—
Trade value
—
% of position
71.1%
3/1/2025
22.87K→39.12K
Common Stock
Direct
Shares
−5.69K
Price / share
$2.35
Trade value
$13.37K
% of position
14.5%
3/3/2025
39.12K→33.43K
Total
Net shares
+10.56K
Net value
-$13.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | M · Option Exercise | +16.25K | — | — | 71.1% | 22.87K | 39.12K |
| Common Stock Direct | 3/3/2025 | S · Sale | −5.69K | $2.35 | $13.37K | 14.5% | 39.12K | 33.43K |
| Total | +10.56K | -$13.37K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
16.25K shares
Shares
−16.25K
Strike price
Held after
48.75K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock16.25K shares | 3/1/2025 | M · Option Exercise | −16.25K | — | 48.75K |